GPT and fatty liver disease: It has been recently demonstrated that patients with liver steatosis and elevated alanine transaminase (ALT) levels associate an increased risk of developing cirrhosis (adjusted hazard ratio 3.37; 95% confidence interval 2.34–4.86; p < 0.01).